Exhibit 10.40

ORAMED PHARMACEUTICALS INC.

Annual Report on Form 10-K

EXHIBIT [__].1

ENGLISH SUMMARY OF LOAN AGREEMENT

By and Among Oramed Ltd. and Tova Hochma Im Nachala Ltd. (as Lenders)

and Project Hafasga – Telefoniot HaHadasha Ltd. (as Borrower)

(Originally Executed in Hebrew)

Dated March 24, 2025

1. Note Regarding Foreign Language Document

This document constitutes an English-language summary of a Loan Agreement (the “Agreement”) originally executed in Hebrew on March 24, 2025. This summary is provided pursuant to Rule 306 of SEC Regulation S-T (17 C.F.R. § 232.306), which requires that any document filed in a foreign language be accompanied by either a complete English translation or an English-language summary of the material terms. The Registrant has elected to provide this summary in lieu of a complete translation. The original Hebrew-language Agreement is filed as a sub-exhibit hereto. In the event of any inconsistency between this summary and the original Hebrew text, the Hebrew text shall control.

2. Parties to the Agreement

2.1 Lenders

2.2 Borrower

3. Principal Financial Terms

4. Purpose of the Loan

The loan proceeds serve as partial consideration for a real estate purchase transaction (the “Sale Agreement”) entered into on October 15, 2024 between the Borrower and the Greek Orthodox Patriarchate of Jerusalem (the “Patriarchate”). Under the Sale Agreement, the Borrower agreed to purchase certain real property in Jerusalem for a total consideration of NIS 200,000,000. The first installment of the purchase price (NIS 100,000,000) is to be funded using the loan proceeds and remitted to the Patriarchate promptly following disbursement.

5. Subject Property

6. Disbursement Conditions

Disbursement of the loan principal is conditioned upon satisfaction of all of the following:

All payments shall be denominated in U.S. Dollars and converted to NIS at the Bank of Israel representative rate on the date of payment. The Lenders’ respective portions shall be held in separate accounts.

7. Security / Collateral

8. Repayment and Prepayment

Full repayment of principal and interest is due within 12 months from the Loan Commencement Date.

Voluntary prepayment is permitted at any time, subject to: (i) a minimum interest period of 6 months; (ii) not less than 30 days’ prior written notice to the Lenders; and (iii) payment of minimum interest for the 6-month period in any case. Repayment to Oramed Ltd. is to be made to its USD account at Bank Discount; repayment to Tova Hochma Im Nachala Ltd. to its account at Bank Mizrahi-Tefahot.

9. Events of Default and Acceleration

10. Transfer of Rights

The Lenders are aware that the Borrower intends to prepay the loan in connection with a combination transaction with a third party. Upon full repayment, the Lenders shall release all security interests. The Borrower may not assign its rights or obligations without the prior written consent of the Lenders. The Lenders shall not unreasonably withhold consent to transfer of the security package to the combination entity, subject to the Borrower’s compliance with all terms of the Agreement.

11. General Provisions

12. Annexes to the Original Agreement

* * * 

This summary has been prepared by the Registrant based on the original Hebrew-language Agreement. In the event of any inconsistency between this summary and the original Hebrew text, the Hebrew text shall control.